Tamarse, Marielle .
HRN: 28-12-15 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2025
AMPICILLIN 1GM (VIAL)
12/17/2025
12/23/2025
IV
1.5gm
Q6hr
PROM
Waiting Final Action
12/17/2025
AMPICILLIN 1GM (VIAL)
12/17/2025
12/23/2025
IV
2g
Every 6 Hours
PROM
Waiting Final Action
12/17/2025
CO-AMOXICLAV 625MG (TAB)
12/17/2025
12/24/2025
ORAL
625mg
BID
PROM
Checking Final Appropriateness